- Home
- PRME vs FUND Comparison
PRME vs FUND Comparison
Compare PRME & FUND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- FUND
- Stock Information
- Founded
- PRME 2019
- FUND 1988
- Country
- PRME United States
- FUND Canada
- Employees
- PRME N/A
- FUND N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- FUND Investment Managers
- Sector
- PRME Health Care
- FUND Finance
- Exchange
- PRME Nasdaq
- FUND Nasdaq
- Market Cap
- PRME 191.7M
- FUND 214.9M
- IPO Year
- PRME 2022
- FUND N/A
- Fundamental
- Price
- PRME $2.71
- FUND $7.55
- Analyst Decision
- PRME Buy
- FUND
- Analyst Count
- PRME 6
- FUND 0
- Target Price
- PRME $9.38
- FUND N/A
- AVG Volume (30 Days)
- PRME 3.3M
- FUND 32.5K
- Earning Date
- PRME 08-04-2025
- FUND 01-01-0001
- Dividend Yield
- PRME N/A
- FUND 6.64%
- EPS Growth
- PRME N/A
- FUND N/A
- EPS
- PRME N/A
- FUND 0.93
- Revenue
- PRME $3,846,000.00
- FUND N/A
- Revenue This Year
- PRME $104.12
- FUND N/A
- Revenue Next Year
- PRME $196.78
- FUND N/A
- P/E Ratio
- PRME N/A
- FUND $8.33
- Revenue Growth
- PRME 550.76
- FUND N/A
- 52 Week Low
- PRME $1.11
- FUND $6.75
- 52 Week High
- PRME $6.75
- FUND $8.47
- Technical
- Relative Strength Index (RSI)
- PRME 69.76
- FUND 62.58
- Support Level
- PRME $1.56
- FUND $7.35
- Resistance Level
- PRME $2.78
- FUND $7.51
- Average True Range (ATR)
- PRME 0.26
- FUND 0.09
- MACD
- PRME 0.08
- FUND -0.00
- Stochastic Oscillator
- PRME 76.81
- FUND 79.23
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About FUND Sprott Focus Trust Inc.
Sprott Focus Trust Inc is a diversified closed-end investment company. Its primary investment objective is long-term capital growth. To achieve its objective, The Fund may invest its assets in equity securities and in direct obligations of the U.S. Government or its agencies and in the non-convertible preferred stocks & debt securities of domestic and foreign companies. It invests in various sectors, of which Materials, Financials, Energy, Information technology sector account for the majority weightage.